Jan. 8, 2024 7:58 am ET

Boston Scientific will acquire Axonics for about $3.7 billion in cash.

The companies said on Monday that Axonics had agreed to be bought for $71 a share. Boston Scientific said the deal gave Axonics an equity value of $3.7 billion and an enterprise value of $3.4 billion.

Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Congress averts shutdown with hours to spare, sending funding bill to Biden’s desk

WASHINGTON — The House passed legislation to keep the government running until…

Houston Businesses Emerge From Storm

HOUSTON—As Henry Nguyen reopened his hair salon in southwest Houston, half a…

Here’s Where Beach House Rentals Earn the Most Revenue

As hopeful home buyers flounder in a frustrating market, many are opting…

Justice Department Makes Quiet Push on Antitrust Enforcement

WASHINGTON—The Justice Department has been quietly ramping up antitrust enforcement under the…